Hot topics close

Food and Drug Administration

Post-COVID Wave Ahead of Death, Disability From Chronic Disease
60
  • Post-COVID Wave Ahead of Death, Disability From Chronic Disease
  • FDA Approves First Long-Acting HIV Drug Combo
  • Glaxo (GSK) Gets FDA Nod for Long-Acting HIV Regimen Cabenuva
  • FDA approves 1st long-acting HIV drug combo, monthly shots
  • Glaxo (GSK) Gets FDA Nod for Long-Acting HIV Regimen Cabenuva
  • FDA Approves 1st Long-Acting HIV Drug Combo, Monthly Shots
  • ViiV Healthcare announces FDA approval of Cabenuva (cabotegravir, rilpivirine), the first and only complete long-acting regimen for HIV treatment
  • More countries approve once-a-month ARV
  • FDA Approves First Extended-Release, Injectable Drug Regimen for Adults Living with HIV
  • FDA Approves First Monthly Injection For People Living with HIV
  • False negative? FDA warns of possible issue with Curative COVID-19 test
  • FDA issues warning about risk of false negatives with Curative's COVID-19 test
  • Coronavirus updates: New saliva test a 'huge step forward'; Birx urges Americans to wear masks indoors and outdoors
  • GW Pharma's stock rallies after its cannabinoid drug gets a new FDA approval
  • Guatemala angry over coronavirus-infected deportees: Live updates
  • Coronavirus: Health board 'could not test suspected Covid patients'
  • Other news to note for May 11, 2020 | 2020-05-11 | BioWorld
  • Other news to note for May 11, 2020 | 2020-05-11 | BioWorld
  • Telemedicine Clinic Partners With Aidoc to Roll Out AI Diagnostics Tools
  • U.S. FDA commissioner in self-quarantine after exposure to person with COVID-19